Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-27

Clinical Trial Update: A Study of CX157 (TriRima) for the Treatment of Depression [Phase 2]

View source ↗

Summary

This Phase 2 trial of CX157 (TriRima) for Major Depressive Disorder has completed and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CX157 (TriRima) (CX157)

Snippet

Sponsor: CeNeRx BioPharma Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2012-06-27